Sign in or Register

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Novel Coronavirus (SARS-CoV-2)

Coronaviruses were first identified in the 1960s with crown-like shape, which are associated with a wide range of respiratory symptoms. Coronaviruses, such as the Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV), can lead to aggravated symptoms in humans, including severe pneumonia, acute respiratory syndrome and death...

Cancer Research

Cancer cells are cells that divide relentlessly, forming solid tumors or flooding the blood with abnormal cells. Cell division is a normal process used by the body for growth and repair. We have a broad selection of research antibodies to help your projects in the research of autophagy, metastasis, proliferative signaling...

Antibody Array

Antibody arrays are valuable for the parallel analysis of multiple proteins in small sample volumes. Antibody arrays have facilitated advances in basic biology and discoveries towards potential tools of clinical use. Sandwich assays and label-based assays have been used to measure multiple protein abundances for biomarker discovery and biological studies...